Objectives: 1. Explore a new treatment protocol
2. Learn how to practically treat patients with facial photoaging who deserve more than a simple photorejuvenation but are not willing to accept a long downtime procedure
3. Understand how 2 different technologies can be synergistic if used sequentially
Introduction: The constant research to obtain an aesthetic improvement of the face with a rapid recovery and a minimum risk is at the basis of a new treatment protocol. Efficacy and safety of a new sequential (same session) use of IPL and microneedle radiofrequency and galvanic energy for facial rejuvenation have been evaluated.
Materials / method: 212 patients with mild to moderate facial solar elastosis have been enrolled since 2018. The new therapeutic protocol consists of 4 treatment sessions at 30-40 days interval. A full face OPT - IPL photorejuvenation procedure is immediatelly followed by a 3 pass hybrid energy MRF procedure The degree of photoaging and the efficacy of treatment were evaluated using a modified Dover's scale (5 point scale for global score, fine lines, mottled pigmentation, sallow complexion, tactile roughness and coarse wrinkles). The follow-up was at 6 months after the end of the last treatment session.
Results: All the variables of the modified Dover’s scale showed a statistically significant improvement in the majority (> 75%) of patients and only minor adverse events have been recorded.
Conclusion: It is hypothesized that the observed improvement could be attributed to the synergistic effect of the 2 technologies used sequentially. The IPL treatment, by increasing the tissue temperature and increasing the water content of tissues, could allow a greater and deeper diffusion of the radiofrequency explaining, consequently, the results that can be observed on collagen production
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.